Disease Prevention and Treatment translates research findings from around the world into actionable, evidence-based protocols for the prevention and management of 130 common health concerns. This is the only book available to present thorough strategies for the promotion of good health using natural compounds, hormones, novel pharmaceutical agents, and comprehensive blood testing to complement conventional standard-of-care regimens and combat the diseases of aging. The 5th edition has been comprehensively updated to provide the latest scientific findings on the optimal management of conditions ranging from cancer and cardiovascular disease, to arthritis and neurological disorders. Each protocol within this book contains detailed suggestions, based on Life Extension's careful evaluation of thousands of peer-reviewed studies, that can help patients and physicians break free of the conventional one-size-fits-all approach to disease management. For the past 33 years, Life Extension has published life-saving information a decade or more ahead of conventional medicine. A case-in-point is Life Extension's advice to take low-dose aspirin to prevent heart attacks. While mainstream hospitals like Johns Hopkins now advocate aspirin to prevent heart attacks, the Life Extension Foundation published evidence about aspirin's benefits back in 1983. The Life Extension Foundation then spent 15 years battling the FDA to force the agency to recognize the cardio-protective effects of low-dose aspirin. When a serious medical disorder develops, most people have no one to turn to other than their doctor. The problem is that physicians are often too busy to keep up with the latest research findings. As a result, many patients suffer and die even though advanced therapies already exist that could cure them. For example, in 2005 "Tamiflu" became a household word as fears of an avian flu epidemic caused a shortage of this anti-viral drug. Those who purchased the year 2003 edition of Disease Prevention and Treatment, however, learned about Tamiflu before the public and were advised about the benefits of having it available to prevent a flu virus infection. A stark illustration of the failure of doctors to recognize the value of life-saving medical breakthroughs was a study showing that the drug cimetidine improved survival odds in a group of colon cancer patients.40 In this landmark study, patients with an aggressive form of colon cancer took 800 mg of cimetidine for one year after surgery. After ten years, there was nearly a 60% improvement in survival in the group that took cimetidine. As early as 1985, the Life Extension Foundation recommended cimetidine as an adjuvant cancer therapy. If you had been a Life Extension member and contracted colon cancer, your odds of dying could have been reduced dramatically. Many colon cancer patients learned about the enormous value of cimetidine in the year 2003 edition ofDisease Prevention and Treatment. The brand new 2014 edition of Disease Prevention and Treatment provides even more novel therapies for colon cancer patients to consider. For those afflicted with chronic illnesses, the new information contained in the 2014 edition of Disease Prevention and Treatment could result in a liberating experience. When a medical concern arises, you don't want to be left in the darkness of scientific ignorance. By keeping the latest edition of Disease Prevention and Treatment close by, you will quickly be able to use the expanded index to educate yourself about novel therapies that have shown efficacy in peer-reviewed studies, but have not yet made it into conventional medical practice.